Axes 1–2
Traceability and studiedness
Scored using the available matching evidence. Identity: A commercial strain code is printed. Quantity disclosure: 100.0%. Potency: Potency is stated through expiry.
product · release 2026-09-20
US Pharmaceutical Corporation Provida OB
Structured fields rendered from the release dataset. Unknown values retain a reason; price is outside GIS.
Organisms, fibers and substances on this label
Printed organisms · observed
Organism list
Quantities reflect printed organism rows.
| Printed name and notes | Normalized organism | Printed code | Printed deposit | Printed quantity | Flags |
|---|---|---|---|---|---|
| Lactobacillus casei KE-99 | Lacticaseibacillus casei | KE-99 | not printed | 200,000,000,000 CFU | T3; observed; quantity printed |
Pack, dose and cost
What the label says beyond the organisms
- Pack
- 30 Capsule(s) · Capsule
- Serving
- 1 Capsule(s) · 1 serving(s) a day
- Days of supply
- 30
- Potency per day
- 200,000,000,000 CFU
- Cost per day
- no observed price in this release
- Printed claims
- 3 on the label (Nutrient , All Other, Structure/Function). A printed claim is not evidence and does not enter any axis.
- Other ingredients
- 6 printed: Titanium Dioxide, FD&C Blue #1, FD&C Red #40, Hypromellose, Magnesium Stearate, Microcrystalline Cellulose
- Label target groups
- Children 4 or More Years of Age, Pregnant Women, Adult Female (18 - 50 Years), Lactating
- Suggested use
- Dosage and administration: Adults (persons over 12 years of age), one (1) capsule daily, between meals, or as prescribed by a physician. Do not exceed recommended dosage. Do not administer to children under the age of 12.
- UPC
- 3 52747 50430 4
Printed potency
Quantity on the label
200,000,000,000 CFU per serving across 1 of 1 printed organism rows; potency basis Potency is stated through expiry.
Evidence behind the label
Located human trials per organism
| Organism on this label | PubMed records indexed as human randomized controlled trials |
|---|---|
| Lacticaseibacillus casei | 240 |
| Lacticaseibacillus casei KE-99 | 0 |
Counts describe records matching each organism's published query, including trials of multi-ingredient products; they are not a count of trials of this product.
Context
Where this score sits
This formulation scores above 8% of the 4,101 scored formulations in this release. The score is a preference-dependent summary of the axes, not a health claim.
| Other products carrying the same strain | Shared strain | Gut Index Score | Observed price |
|---|---|---|---|
| US Pharmaceutical Corporation Restora | KE-99 | 33.52 | not observed |
A189.50
A20.00
GIS40.27
Axes 3–4
Measurement and brand panel
Not a measurement product, so this axis does not apply.
No brand review panel is published in this release.
Price column
Observed price
undefined: no permitted price observation in this release
Sensitivity
Preference-dependent summary
Preference interval 0.00–45.32; rank uncertainty 2843.00–3260.00; rank class 4.
Versions
Typed label snapshot edges
- 241381 → 304795: snapshot comparison. organisms added: Lactobacillus casei KE-99. organisms removed: Lactobacillus casei (KE-99).
- 241381 → 304795: snapshot comparison. organisms added: Lactobacillus casei KE-99. organisms removed: Lactobacillus casei (KE-99).
- 241381 → 304795: snapshot comparison. organisms added: Lactobacillus casei KE-99. organisms removed: Lactobacillus casei (KE-99).
Preference tool
Weights slider
The readout recomputes the arithmetic summary from the published component JSON. Axis fields remain primary.
Elsewhere in this release
Related pages
Findings computed over the whole corpus: Potency basis census · Strain dose match · Supplier code network
Tools: Unit value calculator · DSLD product check
Citation
Cite this page
Ivitskiy, I. (2026). US Pharmaceutical Corporation Provida OB. Gut Registry, release 2026-09-20. Elanvale Ltd. https://gutregistry.com/p/provida-ob/
The underlying tables are published under CC BY 4.0: this page as CSV · as JSON · full release and data dictionary. Cell-level provenance names the source record and its observation date.
Citable atoms
Release claims
US Pharmaceutical Corporation Provida OB: 1 of 1 observed organisms name a strain, and 0 print a deposit identifier. Latest observed label 304795. Window: NIH DSLD snapshot Sep 2026.
1 / 1 observed organisms · NIH DSLD snapshot Sep 2026 · product.organisms · checked 2026-09-20T00:00:00Z · snapshot b7633f732437US Pharmaceutical Corporation Provida OB: 2 of 2 observed label snapshots state a potency basis; latest basis is through expiry. Quantities reflect printed organism rows. Window: NIH DSLD snapshot Sep 2026.
2 / 2 observed label snapshots · NIH DSLD snapshot Sep 2026 · product.potency · checked 2026-09-20T00:00:00Z · snapshot b7633f732437US Pharmaceutical Corporation Provida OB: 1 of 1 selected label snapshots have a numeric Gut Index Score; GIS 40.27 on the 100-point scale; rank class 4 of 4 across 3,279 scored formulations; nominal weights varied from 80.0% to 120.0% in preference sensitivity. Window: NIH DSLD snapshot Sep 2026.
1 / 1 selected label snapshots · NIH DSLD snapshot Sep 2026 · product.gis · checked 2026-09-20T00:00:00Z · snapshot b7633f732437US Pharmaceutical Corporation Provida OB has 2 observed versions across 2 formulation groups; last recorded edge type: available at the same time. Window: NIH DSLD snapshot Sep 2026.
2 / 2 formulation groups · NIH DSLD snapshot Sep 2026 · product.versions · checked 2026-09-20T00:00:00Z · snapshot b7633f732437US Pharmaceutical Corporation Provida OB: 0 of 2 observed versions have numeric prices; latest price No numeric price observation is available in this release.. Window: NIH DSLD snapshot Sep 2026.
0 / 2 observed label versions · NIH DSLD snapshot Sep 2026 · product.price · checked 2026-09-20T00:00:00Z · snapshot b7633f732437